Aduro Clean Technologies (ACT) Q3 2026 earnings summary

Executive summary

• Advanced scale-up and commercialization with NGP pilot plant moving from commissioning to active operation, enabling real-world data generation and process refinement.

• Progressed FOAK industrial program at Chemelot, Netherlands, with early-stage engineering and site development activities.

• Expanded commercialization through partnerships, technical validation, and downstream engagement, including a Letter of Intent for offtake and a licensing MOU.

• Strengthened capital position via a US public offering and over-allotment, supporting ongoing R&D and project development.

Financial highlights

• Q3 2026 revenue was nil, down from $63,399 in Q3 2025; nine-month revenue rose 7% year-over-year to $167,206.

• Q3 2026 loss from operations was $1.63 million, a 43% improvement from Q3 2025; nine-month loss increased 71% year-over-year to $14.42 million.

• Adjusted EBITDA for Q3 2026 was $(2.77) million, down from $(1.84) million in Q3 2025; nine-month adjusted EBITDA was $(8.33) million, a 52% increase in loss year-over-year.

• Cash position rose to $39.42 million as of February 28, 2026, up from $6.96 million at Q4 2025, mainly due to the public offering.

• Property, plant, and equipment value increased to $8.17 million, up 99% from Q4 2025, reflecting NGP pilot plant construction.

Outlook and guidance

• Ongoing NGP pilot plant operations will inform FOAK facility engineering and commercial deployment.

• Proceeds from recent capital raise will fund FOAK development, R&D, and commercialization initiatives.

• Focus on establishing licensing and offtake agreements to support a future license-driven business model.